Rab Diagnostics
ApprovedWe support predictive biomarker discovery and validation for improving Antibody-Drug-Conjugate (ADC)-therapeutics in oncology using our proprietary RabCANCER platform.
Founded
2003
Focus
Diagnostics
About
We support predictive biomarker discovery and validation for improving Antibody-Drug-Conjugate (ADC)-therapeutics in oncology using our proprietary RabCANCER platform.
Funding History
1Total raised: $1.2M
Seed$1.2MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2003
LocationOslo, Norway
StageApproved
Contact
SIMILAR COMPANIES
Algipharma
Phase 1 · Bergen
Bio-Me
Pre-clinical · Oslo
CardiNor
Pre-clinical · Oslo
Gentian USA
Pre-clinical · Moss
Hemispherian
Phase 1 · Oslo
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile